NEW YORK (GenomeWeb) – Pathway Genomics today announced that it has raised $40 million in a Series E round of financing.

"This capital will allow us to continue to expand and validate the tests we offer, grow our sales force, and invest in cutting-edge technology for our CAP- and CLIA-accredited laboratories," Pathway Genomics Founder and CEO Jim Plante said in a statement.

Among the participants in the round is IBM Watson, which is working with Pathway Genomics on the development of a mobile application for personalized health and wellness guidance.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.